SRI-011381 25 mg | 99.11%
TargetMol

SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer’s disease.
More Information Supplier PageSRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer’s disease.
More Information Supplier PageSRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer’s disease.
More Information Supplier PageSRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer’s disease.
More Information Supplier PageBilastine is a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action.
More Information Supplier PageXMU-MP-1 is an inhibitor of the pro-apoptotic, sterile 20-like kinases MST1 and 2.
More Information Supplier PageDelpazolid, also known as LCB01-0371, is a new oxazolidinone with cyclic amidrazone. In vitro activity of LCB01-0371 against 624 clinical isolates was evaluated and compared with those of linezolid, vancomycin, and other antibiotics. LCB01-0371 showed good activity against Gram-positive pathogens. In vivo activity of LCB01-0371 against systemic infections in mice was also evaluated. LCB01-0371 was […]
More Information Supplier PageParis saponin VII (Dioscini) shows inhibitory effects on cell proliferation.
More Information Supplier PageSibofimloc (Antibiotic-202), an antibiotic compound, is used in treating bacterial infections.
More Information Supplier PageAST 487 is a RET kinase inhibitor, inhibiting RET autophosphorylation and activation of downstream effectors. It also can inhibit Flt-3.
More Information Supplier PageBilastine is a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action.
More Information Supplier Page